... of HumanImmunodeficiencyVirus Type 1 (HIV-1) and inactivate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling ...
... the humanimmunodeficiencyvirus, is the most frequently ...Barr virus can be associated with transient lymphocytopenia and CD4+ T ...by human herpes virus has not been ...of ...
... Introduction. Chronic liver disease (CLD) is becoming a major cause of mortality in patients who are positi- ve with humanimmunodeficiencyvirus (HIV). Our aim was to assess the prevalence of CLD in ...
... Background: In Mexico, the quality of health care for humanimmunodeficiencyvirus (HIV) patients is unknown. The study objectives were to develop quality of care (QoC) indicators for outpatient care ...
... in humanimmunodeficiencyvirus type 1 (HIV-1) reverse transcriptase (RT) in vivo, the first 320 amino acids of RT obtained from 2,236 plasma-derived samples from a well-defined cohort of 1,704 ...
... HIV infection is a complex process and exposure to the virus does not always lead to infection. This is the case of the HESNs who are a key population for identifying protective mechanisms to avoid HIV infection. ...
... The dependent variable subclinical atherosclerosis was defined as having the cIMT value ≥ 0.9 mm and / or AP presence (171). It was recorded as bimodal variable (yes / no). The clinical variables waist circumference, ...
... type-specific human papillomavirus (HPV) distribution was evaluated in human immunodefi- ciency virus (HIV)-positive women from paired cervical and urine ...
... We codified toxic habits in an ordinal way (current, former, or never) while comorbidities were registered on a presence/absence basis. Hepatitis C virus infection (HCV) was defined as detectable viremia or a ...
... Its is well known that certain chemokines such as RANTES and SDF-1 are capable of blocking HIV en- try by binding to HIV co-receptors CCR5 or CXCR4, although their true role in HIV infection has been the subject of ...
... 11. Lozano F, Tirre-Cisneros J, Bascunana A, et al. Prospective evaluation of 25. Supparatpinyo K, Kwamwan C, Baosoung V, et al. Disseminated Penicil- fever of unknown origin in patients infected with the human ...
... of humanimmunodeficiencyvirus type 1– infected children, with or without lipodystrophy (LD), who were receiving highly active antiretroviral therapy (HAART) and in PBL of healthy control subjects ...
... with humanimmunodeficiencyvirus infection and CD4 cell counts of 200 per cubic millimeter or ...advanced humanimmunodeficiencyvirus type 1 infection and prior antiretroviral ...
... to HumanImmunodeficiencyVirus-Infected Individuals (PLWHA); this has led healthcare providers and researchers to make measurements of the health and wellbeing of individuals in very limited manner ...
... HCV and humanimmunodeficiencyvirus (HIV) coin- fection is common in patients who acquire HIV by parenteral routes. Increased survival rates in patients with HIV resulting from the use of highly ...
... of humanimmunodeficiencyvirus type 1 (HIV-1) encodes 15 distinct proteins, three of which provide essential enzymatic functions: a reverse transcriptase (RT), an integrase (IN), and a protease ...
... of humanimmunodeficiencyvirus (HIV)/hepatitis C virus (HCV) coinfected patients, and compare to AST/ALT ratio (AAR), AST to platelet ratio index (APRI) and FIB-4 scores, as a tool for the ...
... In a 9-year period we have detected the histopathological presence of Leishmania in various cutaneous biopsies from humanimmunodeficiencyvirus (HIV)-infected patients with visceral leishmaniasis. ...
... ABSTRACT. In the 1980s, AIDS was considered to be uniformly fatal. Highly active antiretroviral therapy (HAART) has proven effective in reducing morbidity and mortality associated with human ...